Production (Stage)
Belite Bio, Inc
BLTE
$61.61
-$0.02-0.03%
NASDAQ
| 12/31/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 145.15M | -- | 88.16M | -- | -- |
| Total Receivables | 575.00K | -- | 836.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.33M | -- | 916.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 19.00K | 96.47M | 31.00K | 56.14M | 59.14M |
| Total Current Assets | 147.07M | 96.47M | 89.94M | 56.14M | 59.14M |
|
|
|||||
| Total Current Assets | 147.07M | 96.47M | 89.94M | 56.14M | 59.14M |
| Net Property, Plant & Equipment | 965.00K | -- | 1.30M | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 31.00K | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.06M | 4.68M | 3.40M | 1.46M | 1.56M |
| Total Assets | 152.13M | 101.15M | 94.64M | 57.60M | 60.70M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 5.47M | -- | 3.18M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 276.00K | -- | 308.00K | -- | -- |
| Total Finance Division Other Current Liabilities | 302.00K | 4.68M | 149.00K | 4.80M | 4.98M |
| Total Other Current Liabilities | 302.00K | 4.68M | 149.00K | 4.80M | 4.98M |
| Total Current Liabilities | 6.05M | 4.68M | 3.63M | 4.80M | 4.98M |
|
|
|||||
| Total Current Liabilities | 6.05M | 4.68M | 3.63M | 4.80M | 4.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 261.00K | -- | 578.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.31M | 4.68M | 4.21M | 4.80M | 4.98M |
|
|
|||||
| Common Stock & APIC | 254.13M | 96.47M | 162.31M | 52.79M | 55.72M |
| Retained Earnings | -107.65M | -- | -71.50M | -- | -- |
| Treasury Stock & Other | -660.00K | -- | -374.00K | -- | -- |
| Total Common Equity | 145.82M | 96.47M | 90.43M | 52.79M | 55.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 145.82M | 96.47M | 90.43M | 52.79M | 55.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 145.82M | 96.47M | 90.43M | 52.79M | 55.72M |
|
|
|||||